Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Kaiyuan Tang"'
Autor:
Junjie Zhang, Haiyang Guo, Ming Liu, Kaiyuan Tang, Shengke Li, Qiang Fang, Hengda Du, Xiaogang Zhou, Xin Lin, Yanjun Yang, Bin Huang, Dongliang Yang
Publikováno v:
Exploration, Vol 4, Iss 2, Pp n/a-n/a (2024)
Abstract The emergence of drug‐resistant bacteria poses a significant threat to people's lives and health as bacterial infections continue to persist. Currently, antibiotic therapy remains the primary approach for tackling bacterial infections. How
Externí odkaz:
https://doaj.org/article/eb6600cc502b43eda0f5fcecf4b5a2fb
Autor:
Junjie Zhang, Kaiyuan Tang, Runqi Fang, Jiaming Liu, Ming Liu, Jiayi Ma, Hui Wang, Meng Ding, Xiaoxiao Wang, Yanni Song, Dongliang Yang
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Hypoxia is a negative prognostic indicator of solid tumors, which not only changes the survival state of tumors and increases their invasiveness but also remarkably reduces the sensitivity of tumors to treatments such as radiotherapy, chemotherapy an
Externí odkaz:
https://doaj.org/article/71923fde468a41c39fd7fe5d63be7d33
Autor:
Xiaoli Zhang, Wei Chen, Ping Li, Raul Calvo, Noel Southall, Xin Hu, Melanie Bryant-Genevier, Xinghua Feng, Qi Geng, Chenlang Gao, Meimei Yang, Kaiyuan Tang, Marc Ferrer, Juan Jose Marugan, Haoxing Xu
Publikováno v:
eLife, Vol 8 (2019)
Mammalian two-pore-channels (TPC1, 2; TPCN1, TPCN2) are ubiquitously- expressed, PI(3,5)P2-activated, Na+-selective channels in the endosomes and lysosomes that regulate luminal pH homeostasis, membrane trafficking, and Ebola viral infection. Whereas
Externí odkaz:
https://doaj.org/article/fcccf21ebaa14918a7f692c9773d3322
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shufan Duan, Yanling Hu, Ying Zhao, Kaiyuan Tang, Zhijing Zhang, Zilu Liu, Ying Wang, Haiyang Guo, Yuchen Miao, Hengda Du, Dongliang Yang, Shengke Li, Junjie Zhang
Publikováno v:
RSC Advances. 13:14443-14460
This review summarizes the common inorganic and organic photothermal nanoagents and their applications in tumor therapy. Additionally, the challenges and future prospects of nanomaterial-based photothermal therapy in cancer treatment are discussed.
Autor:
Junjie Zhang, Kaiyuan Tang, Zilu Liu, Zhijing Zhang, Shufan Duan, Hui Wang, Hui Yang, Dongliang Yang, Wenpei Fan
Publikováno v:
Nanoscale Horizons; 2/7/2024, Vol. 9 Issue 2, p186-214, 29p
Publikováno v:
Biochemistry; 12/19/2023, Vol. 62 Issue 24, p3455-3464, 10p
Autor:
Xiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, Ryan D. Chow, Kaiyuan Tang, Medha Majety, Meizhu Bai, Matthew B. Dong, Paul A. Renauer, Xingbo Shang, Kazushi Suzuki, Andre Levchenko, Sidi Chen
Publikováno v:
bioRxiv
Chimeric antigen receptor (CAR) T cells are powerful therapeutics; however, their efficacy is often hindered by critical hurdles. Here, utilizing the endocytic feature of the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) cytoplasmic tail (CT),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a627827c905a439c5b5dc10f561098f
https://europepmc.org/articles/PMC10055096/
https://europepmc.org/articles/PMC10055096/
Autor:
Matthew B. Dong, Kaiyuan Tang, Xiaoyu Zhou, Johanna Shen, Krista Chen, Hyunu R. Kim, Jerry Zhou, Hanbing Cao, Erica Vandenbulcke, Yueqi Zhang, Ryan D. Chow, Andrew Du, Kazushi Suzuki, Shao-Yu Fang, Medha Majety, Xiaoyun Dai, Sidi Chen
Publikováno v:
bioRxiv
SummaryCas9 transgenic animals have drastically accelerated the discovery of novel immune modulators. But due to its inability to process its own CRISPR RNAs (crRNAs), simultaneous multiplexed gene perturbations using Cas9 remains limited, especially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd2f3c9fe5579ba654d0138ae9da2021
https://doi.org/10.1101/2023.03.14.532657
https://doi.org/10.1101/2023.03.14.532657
Publikováno v:
Trends Cancer
Recent advances in immunotherapy have fundamentally changed the landscape of cancer treatment by leveraging the specificity and selectivity of the adaptive immune system to kill cancer cells. These successes have ushered in a new wave of research aim